NUTCRACKER

Serial Number 90203676
606

Registration Progress

Application Filed
Sep 23, 2020
Under Examination
May 11, 2021
Approved for Publication
Mar 16, 2021
Published for Opposition
Mar 16, 2021
Registered

Trademark Image

NUTCRACKER

Basic Information

Serial Number
90203676
Filing Date
September 23, 2020
Published for Opposition
March 16, 2021
Abandonment Date
June 17, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 17, 2024
Classes
035

Rights Holder

Nutcracker Therapeutics, Inc.

03
Address
5858 Horton Street, Suite 540
Emeryville, CA 94608

Ownership History

Nutcracker Therapeutics, Inc.

Original Applicant
03
Emeryville, CA

Nutcracker Therapeutics, Inc.

Owner at Publication
03
Emeryville, CA

Legal Representation

Attorney
Susan E. Farley

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 17, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 27, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 23, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 12, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 19, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 19, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 4, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 2, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 2, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 2, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 25, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 5, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 5, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 11, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 16, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 11, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 10, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 26, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Classification

International Classes
035